The University of Southampton
University of Southampton Institutional Repository

MRSD: a quantitative approach for assessing suitability of RNA-seq in the investigation of mis-splicing in Mendelian disease

MRSD: a quantitative approach for assessing suitability of RNA-seq in the investigation of mis-splicing in Mendelian disease
MRSD: a quantitative approach for assessing suitability of RNA-seq in the investigation of mis-splicing in Mendelian disease
Background: RNA-sequencing of patient biosamples is a promising approach to delineate the impact of genomic variants on splicing, but variable gene expression between tissues complicates selection of appropriate tissues. Relative expression level is often used as a metric to predict RNA-sequencing utility. Here, we describe a gene- and tissue-specific metric to inform the feasibility of RNA-sequencing, overcoming some issues with using expression values alone.

Results: We derive a novel metric, Minimum Required Sequencing Depth (MRSD), for all genes across three human biosamples (whole blood, lymphoblastoid cell lines (LCLs) and skeletal muscle). MRSD estimates the depth of sequencing required from RNA-sequencing to achieve user-specified sequencing coverage of a gene, transcript or group of genes of interest. MRSD predicts levels of splice junction coverage with high precision (90.1-98.2%) and overcomes transcript region-specific sequencing biases. Applying MRSD scoring to established disease gene panels shows that LCLs are the optimum source of RNA, of the three investigated biosamples, for 69.3% of gene panels. Our approach demonstrates that up to 59.4% of variants of uncertain significance in ClinVar predicted to impact splicing could be functionally assayed by RNA-sequencing in at least one of the investigated biosamples.

Conclusions: We demonstrate the power of MRSD as a metric to inform choice of appropriate biosamples for the functional assessment of splicing aberrations. We apply MRSD in the context of Mendelian genetic disorders and illustrate its benefits over expression-based approaches. We anticipate that the integration of MRSD into clinical pipelines will improve variant interpretation and, ultimately, diagnostic yield.
0002-9297
210-222
Rowlands, Charlie F.
33e03aa5-fcdd-4f08-ac34-45489338a03c
Taylor, Algy
139b5dfe-f991-41db-88b4-fe6105610d7a
Rice, Gillian I
3b1dd52b-a10e-4576-9d7f-1b4ac26772ac
Whiffin, Nicola
a12b021c-3330-4a73-9dc2-dea3d79ba9a8
Hall, Hildegard Nikki
5e5bbbda-088f-466b-bbd7-d800ae2231d6
Newman, William G.
771e4904-12d6-4b02-8f3f-a0285d95f1a7
Black, Graeme C.M.
5d48343b-c8c4-48e1-b50c-7fe5553e169d
Investigators, kConFab
891de396-ce8d-41e3-9edd-45080200ce58
O'Keefe, Raymond T.
12a7a4ec-4f26-4e66-8621-edd44330a2da
Hubbard, Simon
c1288919-e3a5-497b-bb0c-7dcaeb559ce6
Douglas, Andrew
2c789ec4-a222-43bc-a040-522ca64fea42
Baralle, Diana
faac16e5-7928-4801-9811-8b3a9ea4bb91
Briggs, Tracy A.
d854f462-e537-49e3-8386-12de9ff01b41
Ellingford, Jamie M.
e84f25d6-9c76-44e8-b764-1ec81825032e
Rowlands, Charlie F.
33e03aa5-fcdd-4f08-ac34-45489338a03c
Taylor, Algy
139b5dfe-f991-41db-88b4-fe6105610d7a
Rice, Gillian I
3b1dd52b-a10e-4576-9d7f-1b4ac26772ac
Whiffin, Nicola
a12b021c-3330-4a73-9dc2-dea3d79ba9a8
Hall, Hildegard Nikki
5e5bbbda-088f-466b-bbd7-d800ae2231d6
Newman, William G.
771e4904-12d6-4b02-8f3f-a0285d95f1a7
Black, Graeme C.M.
5d48343b-c8c4-48e1-b50c-7fe5553e169d
Investigators, kConFab
891de396-ce8d-41e3-9edd-45080200ce58
O'Keefe, Raymond T.
12a7a4ec-4f26-4e66-8621-edd44330a2da
Hubbard, Simon
c1288919-e3a5-497b-bb0c-7dcaeb559ce6
Douglas, Andrew
2c789ec4-a222-43bc-a040-522ca64fea42
Baralle, Diana
faac16e5-7928-4801-9811-8b3a9ea4bb91
Briggs, Tracy A.
d854f462-e537-49e3-8386-12de9ff01b41
Ellingford, Jamie M.
e84f25d6-9c76-44e8-b764-1ec81825032e

Rowlands, Charlie F., Taylor, Algy, Rice, Gillian I, Whiffin, Nicola, Hall, Hildegard Nikki, Newman, William G., Black, Graeme C.M., Investigators, kConFab, O'Keefe, Raymond T., Hubbard, Simon, Douglas, Andrew, Baralle, Diana, Briggs, Tracy A. and Ellingford, Jamie M. (2022) MRSD: a quantitative approach for assessing suitability of RNA-seq in the investigation of mis-splicing in Mendelian disease. The American Journal of Human Genetics, 109 (2), 210-222. (doi:10.1101/2021.03.19.21253973).

Record type: Article

Abstract

Background: RNA-sequencing of patient biosamples is a promising approach to delineate the impact of genomic variants on splicing, but variable gene expression between tissues complicates selection of appropriate tissues. Relative expression level is often used as a metric to predict RNA-sequencing utility. Here, we describe a gene- and tissue-specific metric to inform the feasibility of RNA-sequencing, overcoming some issues with using expression values alone.

Results: We derive a novel metric, Minimum Required Sequencing Depth (MRSD), for all genes across three human biosamples (whole blood, lymphoblastoid cell lines (LCLs) and skeletal muscle). MRSD estimates the depth of sequencing required from RNA-sequencing to achieve user-specified sequencing coverage of a gene, transcript or group of genes of interest. MRSD predicts levels of splice junction coverage with high precision (90.1-98.2%) and overcomes transcript region-specific sequencing biases. Applying MRSD scoring to established disease gene panels shows that LCLs are the optimum source of RNA, of the three investigated biosamples, for 69.3% of gene panels. Our approach demonstrates that up to 59.4% of variants of uncertain significance in ClinVar predicted to impact splicing could be functionally assayed by RNA-sequencing in at least one of the investigated biosamples.

Conclusions: We demonstrate the power of MRSD as a metric to inform choice of appropriate biosamples for the functional assessment of splicing aberrations. We apply MRSD in the context of Mendelian genetic disorders and illustrate its benefits over expression-based approaches. We anticipate that the integration of MRSD into clinical pipelines will improve variant interpretation and, ultimately, diagnostic yield.

Text
MRSD_revision-4-plain-text - Accepted Manuscript
Available under License Creative Commons Attribution.
Download (146kB)
Text
1-s2.0-S0002929721004699-main - Version of Record
Available under License Creative Commons Attribution.
Download (2MB)
Text
2021.03.19.21253973v1.full - Other
Available under License Creative Commons Attribution.
Download (1MB)

More information

Accepted/In Press date: 13 December 2021
Published date: 3 February 2022
Additional Information: Acknowledgments C.F.R. is funded by the Medical Research Council (MRC; 1926882) as part of a CASE studentship with QIAGEN. The Baralle lab is sup- ported by an NIHR Research Professorship to D.B. (RP-2016-07- 011). W.G.N. is supported by the NIHR Manchester Biomedical Research Centre (IS-BRC-1215-20007). We acknowledge funding from the Wellcome Trust Transforming Genomic Medicine Initia- tive (200990/Z/16/Z) and the Medical Research Foundation. J.M.E. is funded by a postdoctoral research fellowship from the Health Education England Genomics Education Programme (HEE GEP). The views expressed in this publication are those of the authors and not necessarily those of the HEE GEP

Identifiers

Local EPrints ID: 453057
URI: http://eprints.soton.ac.uk/id/eprint/453057
ISSN: 0002-9297
PURE UUID: 8c77c2a1-4c81-4d97-9d25-0e834b9692c5
ORCID for Andrew Douglas: ORCID iD orcid.org/0000-0001-5154-6714
ORCID for Diana Baralle: ORCID iD orcid.org/0000-0003-3217-4833

Catalogue record

Date deposited: 07 Jan 2022 17:48
Last modified: 17 Mar 2024 03:21

Export record

Altmetrics

Contributors

Author: Charlie F. Rowlands
Author: Algy Taylor
Author: Gillian I Rice
Author: Nicola Whiffin
Author: Hildegard Nikki Hall
Author: William G. Newman
Author: Graeme C.M. Black
Author: kConFab Investigators
Author: Raymond T. O'Keefe
Author: Simon Hubbard
Author: Andrew Douglas ORCID iD
Author: Diana Baralle ORCID iD
Author: Tracy A. Briggs
Author: Jamie M. Ellingford

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×